Hepatic artery infusion chemotherapy for liver metastases in small cell lung cancer
HAI of gemcitabine and FUDR, alongside systemic chemotherapy, may serve as an effective treatment strategy for achieving a high local response and prolonging mOS in patients with LM-SCLC, while also being associated with a relatively low incidence of adverse effects.
Authors
- Wen Zhang (ORCID: https://orcid.org/0000-0001-6118-3136)
- Jialing Lv
- Ruoyu Deng
- Chao Zhang
- Lixia Mu
- Guoyu Xu
Institutions
- Kunming Medical University (CN)
- Qujing Normal University (CN)
Publication Details
- Journal
- Journal of Cancer Research and Therapeutics
- Published
- 2025-12-01
- DOI
- https://doi.org/10.4103/jcrt.jcrt_1171_25
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00